公司資料
AVROBIO 股價、新聞與催化劑
- 股票代碼:
- AVRO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for AVRO.
公司概覽
業務概覽
AVROBIO was a gene-therapy company focused on rare disease before its restructuring and public-market decline. Its platform centered on lentiviral gene therapy and genetic medicine.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, AVRO sat in gene therapy.
商業模式特徵
The company depended on clinical validation, manufacturing, and the ability to create durable value from gene therapy.
生技產業定位
AVROBIO belongs to the historical gene-therapy category rather than the current live public-company set.
未來催化劑
- AVROBIO is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live gene-therapy milestone. The market is mainly waiting on corporate clarity.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。